Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer02:18

Cancer

51.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Complex Genetic Mechanisms in Brain Imaging Genetics via a New Multi-task Learning Method.

IEEE transactions on computational biology and bioinformatics·2026
Same author

stDGCN: A dual-augmentation graph convolutional network for identifying spatial domains with attention mechanism.

IEEE journal of biomedical and health informatics·2026
Same author

Screening criteria for drainage-free patients after retroperitoneal laparoscopic adrenal tumor resection and their prospective validation study value.

Experimental and therapeutic medicine·2026
Same author

MVCL: A Contrastive Learning Model with Multi-view Networks for Driver Gene Prediction.

IEEE journal of biomedical and health informatics·2026
Same author

Phylogenomic and comparative analyses of plastomes of the tribe Marsdenieae (Apocynaceae: Asclepiadoideae): insights into plastome characteristics and generic relationships with an emphasis on Asian genera.

BMC plant biology·2026
Same author

First report of mitochondrial genomes in Hydryphantoidea: novel genomes, evolution rate, and gene rearrangement patterns in two water mites (Acari: Hydrachnidia).

Experimental & applied acarology·2026
Same journal

Mendelian Randomization and Transcriptome Analysis Identify Ischemic Stroke Biomarkers With Putative Relevance to Cerebrospinal Fluid.

BioMed research international·2026
Same journal

Flavonoids and miRNA Modulation: A Novel Approach to Managing Cancer, Diabetes, Depression, and Neurological Disorders.

BioMed research international·2026
Same journal

Enhanced H. pylori Treatment Using a β-Cyclodextrin-Propolis Complex: A Randomized Clinical Trial.

BioMed research international·2026
Same journal

Correction to "C<sub>18</sub>H<sub>17</sub>NO<sub>6</sub> and Its Combination with Scutellarin Suppress the Proliferation and Induce the Apoptosis of Human Glioma Cells via Upregulation of Fas-Associated Factor 1 Expression".

BioMed research international·2026
Same journal

Evaluating a Novel Cell-Free Preservation Solution for Human Cardiomyocyte Protection: A Proof-of-Concept Study.

BioMed research international·2026
Same journal

Clinical Efficacy of Chinese Medicine in Treating Adult Henoch-Schönlein Purpura: A Meta-Analysis.

BioMed research international·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Simulated annealing based algorithm for identifying mutated driver pathways in cancer.

Hai-Tao Li1, Yu-Lang Zhang2, Chun-Hou Zheng3

  • 1College of Information and Communication Technology, Qufu Normal University, Rizhao 276826, China.

Biomed Research International
|July 2, 2014
PubMed
Summary
This summary is machine-generated.

This study presents a new computational method to identify cancer driver pathways by distinguishing functional mutations from passenger mutations using gene expression and mutation data. The enhanced approach proves efficient and applicable to real biological datasets.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.0K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Related Experiment Videos

Last Updated: Apr 27, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.0K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Area of Science:

  • Computational biology
  • Genomics
  • Cancer research

Background:

  • Next-generation sequencing enables large-scale cancer genomics.
  • Distinguishing driver mutations from passenger mutations is a key challenge in cancer research.

Purpose of the Study:

  • To introduce a modified method for the maximum weight submatrix problem to identify cancer driver pathways.
  • To enhance an integrative model combining gene mutation and expression data.

Main Methods:

  • Modified maximum weight submatrix algorithm.
  • Integration of gene mutation and expression data.
  • Evaluation on simulated and real biological datasets.

Main Results:

  • The proposed method demonstrates higher efficiency compared to existing approaches on simulated data.
  • The method is successfully applied to real biological datasets, showing practical applicability.

Conclusions:

  • The developed method effectively identifies cancer driver pathways.
  • This approach aids in distinguishing functional mutations crucial for cancer development.